Plerixafor Injection, Solution
Product Images NDC 25021-416

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Plerixafor (NDC 25021-416). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Ple03 0000 01)

Chemical structure of plerixafor, showing its molecular framework with connected nitrogen-containing ring structures and a central benzene ring.*

FDA Label Image

Package Label – Principal Display Panel – Vial Label (Ple03 0000 02)

Label for Plerixafor Injection 24 mg per 1.2 mL (equivalent to 20 mg per mL) solution for subcutaneous injection. The single-dose vial contains 1.2 mL. Manufactured for Sagent Pharmaceuticals, Schaumburg, IL, USA, and made in India. Includes NDC 25021-416-01 and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.